Pharmacovigilance & Medical Information: An Integrated Approach

Learn how you can achieve an integration of Pharmacovigilance and Medical Information from our real-world experience.

Pharmacovigilance & Medical Information: An Integrated Approach

Webinar date & time: May 16th 15:00 CET

Join our webinar and learn how you can achieve this integration from our real-world experience.

Are you interested in learning about the benefits of integrating Pharmacovigilance and Medical Information? Then, join us for our upcoming webinar, where we’ll discuss the advantages of combining these two critical components of drug safety.

Don’t miss out on this opportunity to expand your knowledge and stay up-to-date with the latest trends in drug safety. Register now and take your Pharmacovigilance and Medical Information management to the next level!

This webinar explores the benefits of integrated Pharmacovigilance and Medical Information. We’ll discuss how you can achieve this integration by sharing our real-world experience. Shortly? We aim to help you successfully integrate these functions and realize their positive impact on your operations and patient outcomes.

Join us to learn how integrated Pharmacovigilance and medical information can benefit your organization and ultimately improve patient care.

Register here!

Olga Asimaki - CMD, PhD.

Olga Asimaki - CMD, PhD.

International QPPV / Head of Global Medical Information

Olga Asimaki is a certified Medical Affairs professional with extensive experience in all aspects of Pharmacovigilance and Medical Information. Olga is a post-doctoral Neuroscientist holding an MSc from King’s College London and a PhD in Pharmacology.  Before joining Biomapas, Olga was Head of Pharmacovigilance and Medical Information at AbbVie, leading and developing pharmacovigilance/medical information teams and systems. During her career, she has worked with global teams to successfully launch, implement and maintain a global medical information system and its processes.

Setting up Medical Information In Europe?

Let’s talk how we can team up to conduct them effectively and ensure smooth processes.

Other content that might interest you:

Expert Guidance on PSURs: Ensuring Drug Safety

Expert Guidance on PSURs: Ensuring Drug Safety

The pharmaceutical industry constantly evolves, with new drugs being developed and approved daily. One critical aspect of ensuring the safety and efficacy of these medications is the periodic assessment of their risk-benefit profile. Enter Periodic Safety Update...

Literature Monitoring in Pharmacovigilance

Literature Monitoring in Pharmacovigilance

Incorporating data from medical and scientific literature is a paramount aspect of patient safety. This wealth of knowledge often constitutes a substantial part of the safety profile of medicinal products. From providing insights on potential side effects to shedding...

Pharmacovigilance in Early Phase Clinical Trials

Pharmacovigilance in Early Phase Clinical Trials

Welcome to the fascinating yet complex world of Pharmacovigilance (PV)! This field stands as an indispensable pillar in drug safety, ensuring the well-being of millions around the globe. However, the path is far from smooth; it's full of unique challenges and critical...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information